Inventera, a company specializing in the development of nanomedicines, is showing a remarkable surge of over 140% on its first day of KOSDAQ trading.

[Market Focus] Inventera Surges 140% on First Day of KOSDAQ Listing View original image

As of 9:13 a.m. on April 2, 2026, Inventera was trading at 40,000 won, up 23,400 won (140.96%) from its initial public offering price of 16,600 won.


The core of Inventera lies in its Invinity platform technology, which utilizes nanostructures. The company is validating this technology through clinical trials in both Korea and the United States, and it plans to generate revenue next year by launching a new nano-MRI contrast agent. By 2029, Inventera aims for 3.76 billion won in sales and 2.22 billion won in operating profit through domestic and overseas product sales as well as technology licensing fees.



During the public subscription for general investors held on March 23-24, Inventera posted a competition rate of 1,913.44 to 1, with deposits for subscription amounting to 4.6851 trillion won. In the institutional investor demand forecast, the offering price was set at the top end of the desired range, 16,600 won, with an institutional competition rate of 1,328.28 to 1.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing